Updates in Therapeutics for Parkinson’s Disease

The speaker was Gaurav Chattree, MD, movement disorder specialist at Stanford. He addressed the "phase 3" or "almost phase 3" research pipeline for disease-modification treatments and for symptomatic therapies. Very good presentation and sandpaper. Highly recommend!